This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
- Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy
- Parametric Images of Antibody Pharmacokinetics Based on Serial Quantitative Whole-Body Imaging and Blood Sampling
- Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors
- Efforts to Control the Errant Products of a Targeted In vivo Generator
- Response of LNCaP Spheroids after Treatment with an {{alpha}}-Particle Emitter (213Bi)-labeled Anti-Prostate-specific Membrane Antigen Antibody (J591)
- Parametric Images of Antibody Pharmacokinetics in Bi213-HuM195 Therapy of Leukemia
- An {{alpha}}-Particle Emitting Antibody ([213Bi]J591) for Radioimmunotherapy of Prostate Cancer